Publications and Further Research Outputs
Peer-Reviewed Publications
Butler, E. , Hevey, D., Collier, S., Boland, M., Hanhauser, Y., Connolly, E., Self-Concept and Health Anxiety Relate to Psychological Outcomes for BRCA1/2 Carriers, Psycho-oncology, 2021, pIN PRESS
Boland M.R., Nugent T., Nolan J., O'Mahony J., O'Keeffe S., Gillham C.C., Maguire A., Geraghty J., McCartan D., Evoy D., Prichard R.S., McDermott E.W., Alazawi D., Boyle T.J., Connolly E.M., Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature, Breast Cancer, 28, (1), 2021, p168 - 174
Sarah A McGarrigle and Geraldine Prizeman and Carol Spillane and Niamh Byrne and Amanda Drury and David Mockler and Elizabeth M Connolly and Anne-Marie Brady and Yvonne P Hanhauser, Decision aids for female BRCA mutation carriers: a scoping review protocol , BMJ, 11, (7), 2021, pe045075
Mee, B. and Kirwan, M. and Clarke, N. and Tanaka, A. and Manaloto, L. and Halpin, E. and Gibbons, U. and Cullen, A. and McGarrigle, S. and Connolly, E.M. and Bennett, K. and Gaffney, E. and Flanagan, C. and Tier, L. and Flavin, R. and McElvaney, N.G., What GDPR and the Health Research Regulations (HRRs) mean for Ireland: a research perspective, Irish Journal of Medical Science, 2020
Boland M.R., Ryan E.J., Nugent T., Gilroy D., Kelly M.E., Kennedy J., Maguire A., Alazawi D., Boyle T.J., Connolly E.M., Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients, Journal of Surgical Oncology, 122, (5), 2020, p861 - 868, p861-868
Kirwan M, Mee B, Clarke N, Tanaka A, Manaloto L, Halpin E, Gibbons U, Cullen A, McGarrigle S, Connolly EM, Bennett K, Gaffney E, Flanagan C, Tier L, Flavin R, McElvaney NG., What GDPR and the Health Research Regulations (HRRs) mean for Ireland: "explicit consent"-a legal analysis., Ir J Med Sci, 2020
Guinan EM, Hussey J, McGarrigle SA, Healy LA, O'Sullivan JN, Bennett K, Connolly EM, A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers., BMC cancer, 13, 2013, p138
Guinan E, Hussey J, Broderick JM, Lithander FE, O'Donnell D, Kennedy MJ, Connolly EM, The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors-a pilot study., Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, (7), 2013, p1983-1992
Cooney M, Galvin R, Connolly E, Stokes E, The International Classification of Functioning (ICF) core set for breast cancer from the perspective of women with the condition., Disability and rehabilitation, 35, (9), 2013, p740-8
Marese A Cooney,R. Galvin, E.K.Stokes, E. Connolly, Impairment , activity and participation after breast cancer: the lived experience, 20, (6 (Suppl 1)), 2012, ppp126 - 126
Mee BC, Carroll P, Donatello S, Connolly E, Griffin M, Dunne B, Burke L, Flavin R, Rizkalla H, Ryan C, Hayes B, D'Adhemar C, Banville N, Faheem N, Muldoon C, Gaffney EF, Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue Samples., Biopreservation and biobanking, 9, (4), 2011, p389-398
Carroll PA, O'Mahony D, McDermott R, Boyle T, Dunne B, Kennedy MJ, Connolly EM, Perioperative diagnosis of the positive axilla in breast cancer: a safe, time efficient algorithm., European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 37, (3), 2011, p205-10
McArdle A, O'Riordan C, Connolly EM, Osteopoikilosis masquerading as osseous metastases in breast cancer., Breast cancer (Tokyo, Japan), 2011
Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, Kennedy MJ, Pidgeon G, Connolly EM., Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer., Molecular Carcinogenesis, 50, (8), 2011, p643 - 651
Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV, Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer., Clinical oncology (Royal College of Radiologists (Great Britain)), 22, (4), 2010, p281-8